KCM
RMD icon

Kornitzer Capital Management’s ResMed RMD Stock Holding History

Kornitzer Capital Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-9,356
Closed -$1.38M – 519
2020
Q1 		$1.38M Sell
9,356
-70,949
-88% -$11.3M 0.03% 348
2019
Q4 		$12.4M Buy
80,305
+50,942
+173% +$7.34M 0.22% 143
2019
Q3 		$3.97M Sell
29,363
-930
-3% -$122K 0.07% 276
2019
Q2 		$3.7M Buy
30,293
+4,250
+16% +$471K 0.07% 278
2019
Q1 		$2.71M Buy
26,043
+4,413
+20% +$455K 0.05% 296
2018
Q4 		$2.46M Buy
+21,630
New +$2.32M 0.05% 290

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Kornitzer Capital Management's RMD Position: Q2 2020 in Review

Kornitzer Capital Management sold out of ResMed (RMD) in Q2 2020, closing a stake of 9,356 shares — an estimated $1.38M sold.

Kornitzer Capital Management first reported a position in RMD in Q4 2018 and held it in 6 quarters. The position peaked at $12.4M in Q4 2019. 582 funds tracked by Wall St. Rank hold RMD as of Q2 2020.

  • Kornitzer Capital Management reported no remaining ResMed position as of Q2 2020 after selling out during the quarter.
  • Kornitzer Capital Management sold 9,356 ResMed shares in Q2 2020, an estimated $1.38M.
  • Kornitzer Capital Management first reported a position in ResMed in Q4 2018 and held it in 6 quarters.
  • Kornitzer Capital Management's ResMed position peaked at $12.4M in Q4 2019.
  • 582 funds tracked by Wall St. Rank held ResMed as of Q2 2020.

Based on Kornitzer Capital Management's 13F filing for Q2 2020, filed 3 Aug 2020.